Morgan Stanley Kiniksa Pharmaceuticals, Ltd. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 17, 2024	BUY	$17.63 - $21.74 $22.4 Million - $27.6 Million	1,270,613 New	1,270,613 $25.1 Million
Q1 2024 Aug 16, 2024	SELL	$17.63 - $21.74 $5.73 Million - $7.06 Million	-324,866 Reduced 20.36%	1,270,613 $25.1 Million
Q1 2024 May 15, 2024	SELL	$17.63 - $21.74 $5.73 Million - $7.06 Million	-324,866 Reduced 20.36%	1,270,613 $25.1 Million
Q4 2023 Aug 16, 2024	BUY	$14.37 - $19.07 $22.9 Million - $30.4 Million	1,595,479 New	1,595,479 $28 Million
Q4 2023 Feb 13, 2024	BUY	$14.37 - $19.07 $1.49 Million - $1.98 Million	103,990 Added 6.97%	1,595,479 $28 Million
Q3 2023 Nov 15, 2023	BUY	$13.62 - $20.2 $2.49 Million - $3.69 Million	182,746 Added 13.96%	1,491,489 $25.9 Million
Q2 2023 Aug 14, 2023	SELL	$10.44 - $16.48 $178,304 - $281,461	-17,079 Reduced 1.29%	1,308,743 $18.4 Million
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $7.71 Million - $11.4 Million	720,278 Added 118.95%	1,325,822 $14.3 Million
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $1.26 Million - $1.88 Million	110,359 Added 22.29%	605,544 $9.07 Million
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $451,790 - $620,748	46,290 Added 10.31%	495,185 $6.36 Million
Q2 2022 Oct 27, 2022	BUY	$7.6 - $11.41 $1.42 Million - $2.13 Million	187,050 Added 71.44%	448,895 $4.35 Million
Q2 2022 Aug 15, 2022	BUY	$7.6 - $11.41 $1.42 Million - $2.13 Million	187,050 Added 71.44%	448,895 $4.35 Million
Q1 2022 Oct 27, 2022	SELL	$9.3 - $12.37 $1.74 Million - $2.31 Million	-187,050 Reduced 41.67%	261,845 $2.6 Million
Q1 2022 May 13, 2022	SELL	$9.3 - $12.37 $882,746 - $1.17 Million	-94,919 Reduced 26.61%	261,845 $2.6 Million
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $1.05 Million - $1.54 Million	101,444 Added 39.73%	356,764 $4.2 Million
Q3 2021 Nov 15, 2021	BUY	$11.39 - $16.23 $2.91 Million - $4.14 Million	255,320 New	255,320 $2.91 Million

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$29.9 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

98.1K
Shares

$1.94 Million
0.08% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$779,453
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$592,200
0.51% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $680M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account